Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction
Stock Titan - 17 Mar 2025Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction ...
glsi
Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction ...
Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently
simplywall.st - 01 Apr 2025Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently ...
InvestingPro’s bearish call on GLSI captures 42% downside movement By Investing.com
Investing.com - 07 Jun 2025InvestingPro’s bearish call on GLSI captures 42% downside movement By Investing.com ...
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
GlobeNewswire - 17 Mar 2025Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 ...
Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI)
Seeking Alpha - 06 Feb 2025Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI) ...
(GLSI) Trading Signals
news.stocktradersdaily.com - 25 Jun 2025(GLSI) Trading Signals ...
Greenwich LifeSciences, Inc. SEC 10-Q Report
TradingView - 20 May 2025Greenwich LifeSciences, Inc. SEC 10-Q Report ...
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Cincinnati Enquirer - 27 Jun 2025Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ...
55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently
Yahoo Finance - 05 Mar 202555% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently ...
Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group
Stock Titan - 02 Apr 2025Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group ...
Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI)
Seeking Alpha - 09 May 2025Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI) ...
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
GlobeNewswire - 10 Feb 2025Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 ...
Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026
Stock Titan - 27 Mar 2025Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 ...
Greenwich LifeSciences Provides Update on Commercial Manufacturing
GlobeNewswire - 22 Jan 2025Greenwich LifeSciences Provides Update on Commercial Manufacturing ...
Greenwich LifeSciences reports progress on FLAMINGO-01 trial
Investing.com - 03 Apr 2025Greenwich LifeSciences reports progress on FLAMINGO-01 trial ...
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial
Curetoday - 03 Apr 2025Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial ...
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire - 02 Apr 2025Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial ...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
GlobeNewswire - 27 Mar 2025Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 ...
Laudato Si’ Movement in Indonesia expands ground-level advocacy for climate action
Vatican News - 05 Nov 2024Laudato Si’ Movement in Indonesia expands ground-level advocacy for climate action ...